Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evotec Munich GmbH

Division of Evotec SE
www.kinaxo.com

Latest From Evotec Munich GmbH

Deal Watch: Gilead Partners With Carna On Small Molecule IO Drug Development

Partnership will use Carna’s proprietary lipid kinase drug discovery platform, bringing another aspect to Gilead’s IO efforts. Catalent continues expansion by acquiring Novavax R&D assets; Genfit licenses elafibranor in China to Terns.

Business Strategies Commercial

Why Novo Holdings Has Invested In ‘Hidden Gem’ Oxford Biomedica

Life sciences investor Novo Holdings buys 10% stake in UK gene therapy biotech.

Deals Companies

Emergings in Brief (09/06)

Start-Up showcases these recently launched companies: Anaptys Biosciences, Cohera Medical, KINAXO Biotechnologies, and Seredigm Corp.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Kinaxo Biotechnologies GMBH
  • Evotec Munich
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Evotec SE
  • Senior Management
  • Andreas Jenne, CEO
  • Contact Info
  • Evotec Munich GmbH
    Phone: (49) 89 7007 63 831
    Am Klopferspitz 19a
    Martinsried, D-82152
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register